Viewing Study NCT03486067


Ignite Creation Date: 2025-12-25 @ 12:32 AM
Ignite Modification Date: 2026-02-22 @ 11:20 AM
Study NCT ID: NCT03486067
Status: TERMINATED
Last Update Posted: 2025-04-17
First Post: 2018-03-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of CC-93269, a BCMA x CD3 T Cell Engaging Antibody, in Participants With Relapsed and Refractory Multiple Myeloma
Sponsor: Celgene
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module